Related Experiment Videos
Why is immunotherapy for glioblastoma "Lag"-ging
Dimitrios Mathios1, Michael Lim1
1Department of Neurosurgery, Oncology and Radiation Oncology, Johns Hopkins Hospital, Baltimore, MD, USA.
Oncotarget
|March 1, 2019
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Right insular glioma in right-handed patient with bilateral language dominance: a multimodal guided awake craniotomy. Illustrative case.
Journal of neurosurgery. Case lessons·2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Weight Loss With GLP-1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta-Analysis.
Obesity (Silver Spring, Md.)·2026
Next-generation immunotherapy biologics for glioblastoma.
Frontiers in immunology·2026
Renal oncocytoma: Α case report and literature review.
Oncotarget·2026
Tick-borne tularaemia as a differential diagnosis in ulcerative skin infection and regional lymphadenopathy in children: a case report.
Journal of medical case reports·2026
Pancreatic tuberculosis: Likely originating from peripancreatic tuberculous lymphadenitis.
Hepatobiliary & pancreatic diseases international : HBPD INT·2026